Anixa Biosciences, Inc.

twitter logo
Nasdaq: ANIX
  • Home
  • About
    • Overview
    • Management Team
    • Board of Directors
    • Scientific Advisors
    • Breast Cancer Clinical Advisory Board
    • Cancer Business Advisory Board
  • Technologies
    • CAR-T
      • Introduction
      • Markets
      • Science
      • Collaborators
    • Cancer Vaccines
      • Introduction
      • Markets
      • Science
      • Collaborators
      • Breast Cancer Clinical Advisory Board
  • Pipeline
  • Investors
    • Overview
    • News Releases
    • The Future of Cancer Immunotherapy & Women’s Health
    • Events & Presentations
      • Events
      • Corporate Presentation
    • Stock Information
      • Quote
      • Charts
      • Historical Data
      • Analyst Coverage
    • SEC Filings
      • SEC Filings
    • Financial Reports
      • Annual Reports
      • Quarterly Reports
    • Corporate Governance
      • Governance Documents
      • Committee Charters
  • News
    • Press Releases
    • Anixa In The News
    • Publications
    • YouTube Channel
  • Contact Us

Quarterly Reports

Investors

Investors

  • Overview
  • News Releases
  • The Future of Cancer Immunotherapy & Women’s Health
  • Events & Presentations
    • Events
    • Corporate Presentation
  • Stock Info
    • Quote
    • Charts
    • Historical Data
    • Analyst Coverage
  • SEC Filings
  • Financial Reports
    • Annual Reports
    • Quarterly Reports
  • Governance
    • Governance Documents
    • Committee Charters
  • Investor Resources
    • Investor FAQs
    • Email Alerts
    • Fact Sheet
    • Contact IR
    • RSS News Feed
  • Financial Reports

  • Annual Reports
  • Quarterly Reports
Filter Filings:
Date Form Description Docs XBRL Pages
06/14/13 10-Q Quarterly report pursuant to sections 13 or 15(d)
Related Documents
EX-31
EX-31
EX-32
EX-32
HTML PDF 66
03/25/13 10-Q/A Quarterly report pursuant to sections 13 or 15(d) HTML PDF XBRL Viewer XLS XBRL Files 3
03/18/13 10-Q Quarterly report pursuant to sections 13 or 15(d)
Related Documents
EX-31
EX-31
EX-32
EX-32
HTML PDF 61
09/14/12 10-Q Quarterly report pursuant to sections 13 or 15(d)
Related Documents
EX-31
EX-31
EX-32
EX-32
HTML PDF XBRL Viewer XLS XBRL Files 27
06/14/12 10-Q Quarterly report pursuant to sections 13 or 15(d)
Related Documents
EX-31.1
EX-31.2
EX-32.1
EX-32.2
HTML PDF XBRL Viewer XLS XBRL Files 46
03/16/12 10-Q Quarterly report pursuant to sections 13 or 15(d)
Related Documents
EX-31.1
EX-31.2
EX-32.1
EX-32.2
HTML PDF XBRL Viewer XLS XBRL Files 44
11/30/11 10-Q/A Quarterly report pursuant to sections 13 or 15(d)
Related Documents
EX-10.1
EX-10.2
EX-31.1
EX-31.2
EX-32.1
EX-32.2
HTML PDF 36
10/14/11 10-Q/A Quarterly report pursuant to sections 13 or 15(d) HTML PDF XBRL Viewer XLS XBRL Files 3
09/14/11 10-Q Quarterly report pursuant to sections 13 or 15(d)
Related Documents
EX-10.1
EX-10.2
EX-31.1
EX-31.2
EX-32.1
EX-32.2
HTML PDF 79
06/14/11 10-Q Quarterly report pursuant to sections 13 or 15(d)
Related Documents
EX-31.1
EX-31.2
EX-32.1
EX-32.2
HTML PDF 56
RSS
  • << Previous
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
  • ...11
  • Next >>

Sign up for email Updates

Be The First to Receive Breaking News

Sign Up Now
Logo Itus
twitter logo

Latest News & Events

May 1, 2026

Anixa Biosciences Interview to Air on the RedChip Small Stocks, Big Money™ Show on Bloomberg TV

Read More...
Apr 29, 2026

Anixa Biosciences Announces Issuance of Mexican Patent Covering Breast Cancer Vaccine Technology

Read More...
Apr 22, 2026

Anixa Biosciences Announces Presentation of its Ovarian Cancer CAR-T Therapy at the International Society for Cell & Gene Therapy 2026 Annual Meeting

Read More...

Promising Breast Cancer Vaccine

Copyrights © 2026 Anixa Biosciences, Inc.. All Rights Reserved.
twitter logo Privacy Policy Terms of Use Disclaimer Sitemap